A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.
A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination Utilizing a 3-Period, Crossover Study Design
Sponsor: Eric Solutions LLC
A PHASE1 clinical study on PHA1A, this trial is completed. The trial is conducted by Eric Solutions LLC and has accumulated 4 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Jul 2025 — Oct 2025 [monthly]
Recruiting PHASE1
-
Apr 2025 — Jul 2025 [monthly]
Recruiting PHASE1
-
Mar 2025 — Apr 2025 [monthly]
Recruiting PHASE1
First recorded
Jan 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eric Solutions LLC
- Wockhardt
For direct contact, visit the study record on ClinicalTrials.gov .